Drugs / Jinfukang Koufuye
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT03269162 | Sep 2016 → Sep 2019 | non-small cell lung carcinoma | lihegen | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Jinfukang Koufuye | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03269162 ↗ |
| Route | Oral | “30ml per time, tid, po (d6-21, q21)” NCT03269162 ↗ |